158 related articles for article (PubMed ID: 14768782)
1. Difference of baseline serum copper levels between groups of patients with different one year mortality and morbidity and chronic heart failure.
Málek F; Dvorák J; Jiresová E; Spacek R
Cent Eur J Public Health; 2003 Dec; 11(4):198-201. PubMed ID: 14768782
[TBL] [Abstract][Full Text] [Related]
2. [Serum copper levels in patients with chronic heart failure associated with systolic left ventricular dysfunction and its relation to the severity of cardiac failure].
Málek F; Spacek R; Polásek R; Karel L; Stanka P; Zenáhlíková M; Jiresová E
Vnitr Lek; 2001 Nov; 47(11):753-6. PubMed ID: 11795180
[TBL] [Abstract][Full Text] [Related]
3. [Non-invasive prognostic parameters in chronic heart failure].
Spinar J; Vítovec J; Spinarová L; Toman J
Vnitr Lek; 1996 Jan; 42(1):43-8. PubMed ID: 8629360
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure].
Kuch M; Janiszewski M; Janiszewski M; Braksator W; Mamcarz A; Sadkowska K; Kuch J; Dłuzniewski M
Pol Merkur Lekarski; 2006 Mar; 20(117):285-8. PubMed ID: 16780256
[TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
[TBL] [Abstract][Full Text] [Related]
6. Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure.
Stanton EB; Hansen MS; Sole MJ; Gawad Y; Packer M; Pitt B; Swedberg K; Rouleau JL;
Can J Cardiol; 2005 Jan; 21(1):39-43. PubMed ID: 15685301
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963
[TBL] [Abstract][Full Text] [Related]
8. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
Amigoni M; Meris A; Thune JJ; Mangalat D; Skali H; Bourgoun M; Warnica JW; Barvik S; Arnold JM; Velazquez EJ; Van de Werf F; Ghali J; McMurray JJ; Køber L; Pfeffer MA; Solomon SD
Eur Heart J; 2007 Feb; 28(3):326-33. PubMed ID: 17251259
[TBL] [Abstract][Full Text] [Related]
9. Difference in long-term prognostic value of renal function between ischemic and non-ischemic mild heart failure.
Smilde TD; Hillege HL; Navis G; Voors AA; Brouwer J; van Veldhuisen DJ
Int J Cardiol; 2006 Feb; 107(1):73-7. PubMed ID: 16337501
[TBL] [Abstract][Full Text] [Related]
10. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
[TBL] [Abstract][Full Text] [Related]
11. [Tolerability and efficacy of aldosterone inhibition with canrenone in heart failure: the real-world experience of an outpatient heart failure clinic].
Nassiacos D; Meloni S
Ital Heart J; 2005 May; 6 Suppl 1():51S-65S. PubMed ID: 15945300
[TBL] [Abstract][Full Text] [Related]
12. Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure.
Windram JD; Loh PH; Rigby AS; Hanning I; Clark AL; Cleland JG
Am Heart J; 2007 Jun; 153(6):1048-55. PubMed ID: 17540208
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery bypass grafting in patients with severe left ventricular dysfunction--early and mid-term outcomes.
Shapira OM; Hunter CT; Anter E; Bao Y; DeAndrade K; Lazar HL; Shemin RJ
J Card Surg; 2006; 21(3):225-32. PubMed ID: 16684046
[TBL] [Abstract][Full Text] [Related]
14. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
[TBL] [Abstract][Full Text] [Related]
15. Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study.
Demir M; Kanadasi M; Akpinar O; Dönmez Y; Avkarogullari M; Alhan C; Inal T; San M; Usal A; Demirtas M
Angiology; 2007; 58(5):603-9. PubMed ID: 18024945
[TBL] [Abstract][Full Text] [Related]
16. Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patients.
Kawai K; Kawashima S; Miyazaki T; Tajiri E; Mori M; Kitazaki K; Shirotani T; Inatome T; Yamabe H; Hirata K; Yokoyama M
J Cardiol; 2010 Jan; 55(1):99-107. PubMed ID: 20122555
[TBL] [Abstract][Full Text] [Related]
17. Surgical ventricular remodeling for patients with clinically advanced congestive heart failure and severe left ventricular dysfunction.
Patel ND; Barreiro CJ; Williams JA; Bonde PN; Waldron M; Natori S; Bluemke DA; Conte JV
J Heart Lung Transplant; 2005 Dec; 24(12):2202-10. PubMed ID: 16364872
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure.
Boffa GM; Zaninotto M; Nalli C; Forni M; Tiso E; Razzolini R; Plebani M
Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581
[TBL] [Abstract][Full Text] [Related]
19. Serum copper as a marker of inflammation in prediction of short term outcome in high risk patients with chronic heart failure.
Malek F; Jiresova E; Dohnalova A; Koprivova H; Spacek R
Int J Cardiol; 2006 Nov; 113(2):e51-3. PubMed ID: 16843542
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
Zareba W; Piotrowicz K; McNitt S; Moss AJ;
Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
